Physician profile
Patrick J Chiles
NPI 1639178379
$2,173.62
in general payments reported to CMS, 2019-2025
17 companies · $688 in 2025
The $688 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $35.13 · 2021: $125 · 2022: $19.36 · 2023: $249 · 2024: $519 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $464.05 | 2019-2025 | |
| Glaxosmithkline, LLC. | $426.30 | 2023-2025 | Nucala |
| Aerin Medical INC. | $349.31 | 2020-2025 | |
| Stryker Corporation | $189.66 | 2019-2023 | Minifess Light Seeker |
| Intersect Ent, INC. | $143.82 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $110.49 | 2019 | |
| Medtronic, INC. | $96.30 | 2024-2025 | Propel, Stealthstation S8 Platform, N/A |
| Acclarent, INC | $95.98 | 2019-2023 | Trudi Nav Cable |
| Integra Lifesciences Corporation | $60.24 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Neurent Medical Limited | $47.23 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Smith+Nephew, INC. | $41.17 | 2019-2024 | Halo |
| Alk-Abello, INC | $40.97 | 2019 | |
| Optinose US, INC. | $37.03 | 2019-2024 | |
| Ars Pharmaceuticals Operations, INC. | $23.26 | 2025 | Neffy |
| Regeneron Healthcare Solutions, INC. | $21.17 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $16.95 | 2024 | Inspire |
| Preceptis Medical, INC. | $9.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Chiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.